The arginase-mediated decreased in L-arginine concentrations and the endotoxin-induced downregulation of NOS3 further impair NOS3-derived NO bioavailability in the microvasculature [11], [21], [22], which results in endothelial dysfunction [23]–[27]. This evidence concerns the gene NOS3 and endothelial dysfunction.